Medi Assist completes Paramount integration as margin reaches 20.4%
Key highlights
- Medi Assist reported a 20.4% consolidated EBITDA margin in Q2 FY27, up 331 bps year on year.
- Medi Assist said all Paramount group customers and claims had migrated to its platforms in Q2 FY27.
- Medi Assist’s Q2 FY27 operating revenue was Rs 241.5 crore and EBITDA was Rs 49.2 crore.
- Medi Assist’s H1 FY27 platform and HBA revenue grew 69.8% to Rs 19.8 crore.
powered by IRIS

Medi Assist Healthcare Services Limited said Paramount’s integration was complete in the second quarter of fiscal 2027 (Q2 FY27), when its consolidated earnings before interest, tax, depreciation and amortisation (EBITDA) margin reached 20.4%, versus 17.1% immediately after the acquisition, on Rs 241.5 crore of operating revenue. Management said all group customers and claims had moved to Medi Assist platforms.
Know Medi Assist Healthcare Services inside out
Results, valuation, peers and who's buying, in one view.
Has Medi Assist completed the Paramount integration?
Yes, Medi Assist said the Paramount acquisition integration was fully complete in Q2 FY27. Management said all group customers had been migrated to the Medi Assist platform and all claims were operating on the MAtrix claims platform, while systems, processes, call centres, people and offices were functioning as one organisation from early in the quarter.
Management said a cyber incident in Paramount’s systems in December of the prior year delayed the integration by about one quarter and affected some renewals between January and April. It said there was no standalone Paramount account remaining, making the migrated portfolio the new base for measuring group-business retention over the next three to four quarters.
Medi Assist said its headcount was more than 800 lower than at the time of the Paramount acquisition. Management attributed the Q2 FY27 margin improvement to lower people costs, rationalisation and deployment of artificial-intelligence tools for the Paramount plan, without quantifying the saving from each measure separately.
How far has Medi Assist’s EBITDA margin recovered?
Medi Assist’s EBITDA margin recovered to 20.4% in Q2 FY27, up 331 basis points (bps) year on year and almost 330 bps from the level immediately after the acquisition. Management said the recovery occurred over the last four quarters and on a materially larger quarterly revenue base than before the transaction.
The Q2 FY27 margin was still 1.7 percentage points below the 22.1% reported in Q1 FY26, before the acquisition, but quarterly operating revenue was about Rs 50 crore higher. Q2 EBITDA was Rs 49.2 crore, up 23.9% year on year; for the first half of FY27 (H1 FY27), EBITDA was Rs 97.2 crore, up 19.0%, and the margin was 20.3%, up 103 bps.
Reported profit after tax (PAT) was Rs 21.6 crore in Q2 FY27, up 167.5% year on year, and Rs 49.2 crore in H1 FY27, up 60.2%. Excluding a one-time derivative gain on call-put options classified as exceptional in the prior quarter, underlying H1 FY27 PAT was Rs 46.1 crore, compared with Rs 30.7 crore a year earlier.
Which businesses drove Medi Assist’s H1 FY27 revenue?
Medi Assist’s India third-party administrator (TPA) business remained its main revenue source, generating Rs 437.5 crore in H1 FY27, up 11.9% year on year and representing 91.5% of operating revenue. Consolidated operating revenue, defined as revenue from contracts with customers excluding other income, was Rs 478 crore, an increase of 13.0%.
Within India TPA, group-business revenue was Rs 334.7 crore, up 13.7%, while government-business revenue was Rs 57.3 crore, up 14.0%. Retail TPA revenue fell 1.8% to Rs 45.5 crore, meaning growth in group and government business offset the decline in the retail revenue line.
The platform and health-benefit administration (HBA) business contributed Rs 19.8 crore in H1 FY27, up 69.8% year on year, while international revenue was Rs 20.7 crore, up 1.1%. In Q2 FY27, platform and HBA revenue rose 94.8% to Rs 11.2 crore, compared with 1.2% growth in India TPA revenue to Rs 219.6 crore.
Medi Assist managed Rs 15,104 crore of premiums through TPA in H1 FY27, up 18.8%, and Rs 9,648 crore through its platform model, up 24.8%. It also processed more than 7 million claims in the half year, including international claims from 141 countries through 21,000 providers.
Got a follow-up? Ask IRIS
What is delaying Medi Assist’s revenue conversion?
Retention and the timing of revenue recognition are the main unresolved issues after the integration. H1 FY27 group-business retention was 90.5%, marginally higher quarter on quarter, and management attributed the earlier decline partly to churn in the acquired Paramount portfolio and to the December cyber incident.
Management said it replaced about 80% of retention losses through new business additions, but reports revenue on a 1/365 basis. It said premium growth can take two to three quarters to translate into revenue, particularly where instalment premiums span multiple quarters, and expects retention to return to its historical 93% to 94% range in three to four quarters.
On retained accounts, Medi Assist said same-store growth was about 7% to 8% in H1 FY27, compared with about 8% to 9% earlier. Management said industry group premiums rose 15.8% in H1 while Medi Assist’s group premiums increased by more than 21%, including acquisitions and its own growth.
The balance sheet showed contract liabilities of Rs 321.7 crore at the end of H1 FY27, compared with Rs 280.2 crore at the end of FY26. In the earnings call, management said the increase in contract liability from March to September represented contracts already won whose revenue had not yet entered the profit and loss account.
How is Medi Assist allocating its cash flows?
Medi Assist plans to return about 50% of cumulative adjusted free cash flow to shareholders over rolling five-year periods through ordinary or special dividends and share buybacks. Management said the policy prioritises investment in the platform and growth businesses, as well as balance-sheet requirements, before surplus cash is returned.
The first action under the policy is a share buyback of up to Rs 49.3 crore at Rs 425 per share. Medi Assist reported cash and cash equivalents of Rs 268.3 crore as of September 26, compared with Rs 260.5 crore at the end of FY26, alongside a zero-debt balance sheet.
Net worth was Rs 886.8 crore at the end of H1 FY27, up from Rs 852.4 crore at FY26 end. Management said cash flows released after the Paramount integration would continue to be deployed into growth businesses, subject to the capital-allocation policy announced in the current financial year.
Conclusion
Medi Assist’s results show that the operational disruption from the Paramount acquisition has moved from system migration to revenue conversion and retention normalisation. H1 FY27 operating revenue rose 13.0% to Rs 478 crore, while platform and HBA revenue grew 69.8% to Rs 19.8 crore, giving the business faster-growing revenue streams alongside the India TPA segment.
The next disclosed measures to watch are group retention and the timing of revenue recognition. Management expects retention to return to 93% to 94% within three to four quarters, while it said premium growth can take two to three quarters to appear in revenue; the Rs 49.3 crore buyback is also the first implementation of its rolling five-year cash-return plan.


